Life Sciences
How to Play AstraZeneca as Earnings Approach
Let's see how the charts are shaping up ahead of the numbers Friday.
Moderna's Shots Block COVID, but Its Shares Now Have Risky Side Effects
Let's see how far this pharma name could fall, even as it plays a leading role in the battle against the pandemic.
Reviewing DexCom for a New Strategy
Here's where profit taking should be considered.
Thermo Fisher Scientific Has Strong Charts and Higher Price Targets Ahead
Let's check the charts and indicators.
'A' Is for Buying: Agilent Is Resuming Its Uptrend
Here's how traders can play the stock.
Intuitive Surgical Is Rallying Ahead of Earnings
Traders could go long ISRG at current levels.
Here's How Johnson & Johnson Stock Looks Ahead of Earnings
All eyes will be on JNJ as it releases its numbers Tuesday.
Medtronic Needs to Rebase Before Being Attractive Again
Stand aside and let things "shake out".
Is Soaring Repligen a Buy on This Pullback?
A double in five months has my attention.
Prospective Pickings Are Slim for This Annual Portfolio of Unloved Losers
The current candidates for the 2022 Tax-Loss Selling Recovery Portfolio are few and far between, with only a couple households names in the bunch.